EV Therapeutics develops off-the-shelf neoantigen-based immunotherapies from tumor-derived extracellular vesicles (EVs) and formulates proprietary therapeutic vaccines to enhance cancer treatment efficacy. self-described.
peer of
competitor of
Metrics
marketPRIVATE
msh_idCOM:EVTHERAPEUTICS
localeus
websitehttps://www.evtherapeutics.com/
source_ref24588ae3-82e2-4942-abcd-16f17c8d0e78
company_size1
products_or_servicesneoantigen-based immunotherapies, therapeutic vaccines, cancer treatment
United States